Three-month prostate-specific antigen level after androgen deprivation therapy predicts survival in patients with metastatic castration-sensitive prostate cancer

Naohiro Fujimoto, Masaki Shiota, Takuo Matsukawa, Akinori Minato, Ikko Tomisaki, Rei Ohnishi, Masatoshi Eto

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Three-month prostate-specific antigen level after androgen deprivation therapy predicts survival in patients with metastatic castration-sensitive prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds